Precore Stop Mutant in HBeAg-Positive Patients with Chronic Hepatitis B: Clinical Characteristics and Correlation with the Course of HBeAg-to-Anti-HBe Seroconversion
Open Access
- 1 January 2002
- journal article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 40 (1) , 16-21
- https://doi.org/10.1128/jcm.40.1.16-21.2002
Abstract
This study aimed to investigate the ratios of precore stop mutant (codon 28; TGG to TAG) to total viremia in 53 HBeAg-positive patients with chronic hepatitis B by amplification-created restriction site assays along the course of HBeAg-to-anti-HBe seroconversion. At baseline, 11% had exclusive wild-type hepatitis B virus (HBV), 15% had exclusively precore mutant, and 74% had mixed viral strains. Precore mutant ratios correlated little with age, sex, or HBV DNA levels (allP> 0.1), but correlated modestly with alanine aminotransferase (ALT) levels (P= 0.05). The intervals from presentation to anti-HBe seroconversion correlated significantly with ALT and precore mutant ratios in univariate analysis but with only precore mutant ratios in multivariate analysis (P= 0.003). Precore mutant ratios at baseline were significantly higher (P< 0.001) in six patients with persistent high viremia and ALT elevation after anti-HBe seroconversion (group 1) than in 47 with remission (group 2). All group 1 patients had exclusive precore mutant after anti-HBe seroconversion, as did only 14 (30%) of the group 2 patients (P= 0.003). Among group 2 patients, precore mutant ratios at baseline or after anti-HBe seroconversion showed no significant difference between 34 patients with sustained remission and 13 with relapse. Cirrhosis developed in 50% (5 of 10) of patients with precore mutant ratios >50% at baseline but only in 12% (5 of 43) of those with precore mutant ratios of P< 0.05). In conclusion, precore mutant of variable ratios was frequently detected in HBeAg-positive patients with chronic hepatitis B. Precore mutant ratios tended to correlate with ALT levels and anti-HBe seroconversion, but high precore mutant ratios were associated with persistent hepatitis after anti-HBe seroconversion and increased risk of cirrhosis.Keywords
This publication has 43 references indexed in Scilit:
- Quantitative analysis of serum HBV pre-core mutant in HBV carriers.Kanzo, 1997
- Changes in the prevalence of HBeAg-negative mutant hepatitis B virus during the course of chronic hepatitis BHepatology, 1994
- Absence of Hepatitis B Virus Precore Mutants in Patients With Chronic Hepatitis B Responding to Interferon–αHepatology, 1992
- A prospective randomized trial comparing somatostatin, balloon tamponade and the combination of both methods in the management of acute variceal haemorrhageJournal of Hepatology, 1991
- High prevalence and heterogeneity of HBV preC mutants in anti-HBe-positive carriers with chronic liver disease in Southern ItalyJournal of Hepatology, 1991
- High genomic variability in the pre‐C region of hepatitis B virus in anti‐HBe, HBV DNA‐positive chronic hepatitisJournal of Medical Virology, 1990
- Which Patients With Chronic Hepatitis B Virus Infection Will Respond to α–Interferon Therapy? A Statistical Analysis of Predictive FactorsHepatology, 1989
- Acute exacerbation in chronic type B hepatitis: Comparison between HBeAg and antibody-positive patientsHepatology, 1987
- Natural History of Chronic Hepatitis B Virus Infection in Taiwan: Studies of Hepatitis B Virus Dna in SerumHepatology, 1985
- Contribution of low level HBV replication to continuing inflammatory activity in patients with anti-HBe positive chronic hepatitis B virus infection.Gut, 1984